Tracking social and biological experiences: The social etiology of cardiovascular disease

Circulation

Volumn 111, Issue 23, 2005, Pages 3022-3024

  Berkman, Lisa F ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular disease; Editorials; Mortality; Socioeconomic factors

Indexed keywords

C REACTIVE PROTEIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DIET; EDITORIAL; ETHNOLOGY; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH EDUCATION; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; MORTALITY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; SOCIAL BEHAVIOR; SOCIOECONOMICS;

CARDIOVASCULAR DISEASES; CORONARY DISEASE; HEALTH BEHAVIOR; HEART RATE; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; METABOLIC SYNDROME X; SOCIOECONOMIC FACTORS;

EID: 20544437847     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.509810     Document Type: Editorial

References (16)

1. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88:1973-1998.
2. Health. United States, 1998, With Socioeconomic Status and Health Chartbook. Hyattsville, Md: National Center for Health Statistics; 1998.
3. Davey Smith G. Blane D, Bartley M. Explanations for socioeconomic differences in mortality: evidence from Britain and elsewhere. Eur J Public Health. 1994;4:131-144.
4. Lynch J, Kaplan G, Shema S. Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. N Engl J Med. 1997;337:1889-1895.
5. Arciero T, Jacobsen S, Reeder G, Frye R, Weston S, Killian J, Roger JV. Temporal trends in the incidence of coronary disease. Am J Med. 2004; 117:228-233.
6. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the U.S. 1960-1986. N Engl J Med. 1993;329:103-109.
7. Murray C, Lopez A. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;3:1269-1276.
8. Ebrahim S, Davey Smith G. Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol. 2001;30:201-205.
9. Hemingway H, Shipley M, Brunner E, Britton A, Malik M, Marmot M. Does autonomic function link social position to coronary risk? The Whitehall II Study. Circulation. 2005;111:3071-3077.
10. Tsuji H, Larson M, Venditti F Jr, Manders E, Evans J, Feldman C, Levy D. Impact of reduced heart rate variability on risk for cardiac events. Circulation. 1996;94:2850-2855.
11. Danesh J, Wheeler J, Hirschfield G, Eda S, Eiriksdottir G, Rumley A, Lowe G, Pepys M, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disaese. N Engl J Med. 2004;350:1387-1397.
12. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-179.
13. Singh J, Larson M, Tsuji H, Evans J, O'Donnell C, Levy D. Reduced heart rate variability and new-onset hypertension. Hypertension. 1998; 32:293-297.
14. Singh J, Larson M, O'Donnell C, Wilson P, Tsuji H, Lloyd-Jones D, Levy D. Association of hyperglycemia with reduced heart rate variability (the Framingham Heart Study). Am J Cardial. 2000;86:309-312.
15. Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
16. Marmot MG, Davey Smith G, Stansfield S, Patel C, North F, Head J, White I, Brunner E, Feeney A. Health inequalities among British civil servants: the Whitehall II Study. Lancet. 1991;337:1387-1393.